This website uses cookies to enhance the user experience.
L

LIC SCADENTA AS956 226 635

Purchase and sale
Limited company
Hamangskogen 60 1338 SANDVIKA, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

LIC SCADENTA AS

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
KF

Kristian Funderud Melby1991

Chairman of the board
KJ

Karl Jonas Redin1982

Years since formation
30 years
since Mar 12, 1995
Type
Limited company
VAT registered
Yes
Number of employees
30

Ownership

Number of shares and share classes
1
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Total operating income 2024
171,874,221
NOK
Annual total result 2024
42,566,276
NOK
Total equity 2024
60,161,375
NOK
Last update: Jun 17, 2025

Management

Management / administration

NameRoleShares
KF

Kristian Funderud Melby

1991

Managing Director/CEO-

Board

NameRoleShares
KJ

Karl Jonas Redin

1982

Chairman-
FM

Frida Maria Agge

1982

Board Member-

Others

NameRoleShares
P
PRICEWATERHOUSECOOPERS AS
Auditor-
Last update: Jan 5, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
DA

Dental Ab Dab

Ordinary shares
1
100 %

Shares owned by the LIC SCADENTA AS

NameShare classTotal number of sharesShare
O
OSLO DENTAL AS
Ordinary shares
100
100 %
J
JACOBSEN DENTAL AS
Ordinary shares
830
100 %
T
TECHNOMEDICS NORGE AS
Ordinary shares
100
100 %
Last update: Jun 2, 2025

Group structure

  • LIC SCADENTA AS
    Total operating income 2024: NOK 171,874,221
    Operating profit 2024: NOK 15,810,893
    Employees: 30

Financials

in NOK

Summary

Year2024202320222021
Total operating income
171,874,221
148,458,838
153,496,182
159,174,041
Annual Total Result
42,566,276
10,510,192
42,010,357
49,498,050
Total assets
127,144,376
90,469,305
106,337,886
104,465,728
Total liabilities
66,983,003
30,550,089
46,428,861
70,147,060
Total equity
60,161,375
59,919,216
59,909,025
34,318,668

P&L

Year2024202320222021
Total operating income
171,874,221
148,458,838
153,496,182
159,174,041
Total operating costs
156,063,328
135,874,953
138,511,112
139,884,473
Operating result
15,810,893
12,583,885
14,985,070
19,289,568
Financial income/costs
30,531,232
767,236
30,318,427
34,462,929
Profit before tax
46,342,125
13,351,121
45,303,497
53,752,497
Total tax & extraordinary income/cost
3,775,849
2,840,929
3,293,140
4,254,447
Annual Total Result
42,566,276
10,510,192
42,010,357
49,498,050

Balance overview

Year2024202320222021
Total fixed assets
32,129,848
40,882,540
59,289,498
30,463,639
Total current assets
95,014,528
49,586,765
47,048,388
74,002,089
Total assets
127,144,376
90,469,305
106,337,886
104,465,728
Short term debt
66,983,003
30,550,089
46,428,861
70,147,060
Long term debt
0
0
0
0
Total liabilities
66,983,003
30,550,089
46,428,861
70,147,060
Contributed capital
60,161,375
59,919,216
2,000,000
2,000,000
Retained earnings
0
0
57,909,025
32,318,668
Total equity
60,161,375
59,919,216
59,909,025
34,318,668
Total equity and liabilities
127,144,378
90,469,305
106,337,886
104,465,728

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods